Please click here for link to Economic Times Article
Raziuddin Qadri, February 2017
Mr.K.V.Balasubramaniam’s achievements are well documented in Outlook magazine article titled ‘Ten Percent Solution’ of 30th November 2015 (Web edition). His entire career can be summed up as ‘Over Promise. Under Deliver’. He committed Rs. 1913 Cr turnover in five years – by 2013, and ended up achieving Rs.350 Cr. Again, he committed 1000 Cr in 3 years by 2016 and ended up achieving 370 Cr! This record was Guinness worthy as it fell a full 100 crore plus short of previous year’s actual at 483 Crore in his final year of employment! According to IIL rules, any employee leaving the services of the company cannot join a competitor for a minimum period of one year. How did Mr. KVB whose extension ended in March 2016 join Bharat Serum in the same year? The minimum period of one year was for junior level and non technical employees. So a higher tenure should have been applicable for Managing Director. Mr.K.V.Balasubramaniam violated this basic rule but made hell of many ex-employees lives when they tried to join similar companies. Should anyone trust Bharat Serum and Vaccines Limited anymore when they have at their helm a person not only renowned for his consistent record of poor performance but also violation of his fundamental employment terms?
Ironmanofindiaa, February 2017
This is where it gets murkier. just before retiring, kvb struck a deal with Bharat Serum for marketing rabies vaccine manufactured by IIL. strangely, his staff had been trying similar deals in the past. KVB always managed to torpedo such deals right at the end. he would start negotiating all over again, putting off suitors. Finally he found a potential employer and impressed them with a sweetheart deal, landed himself a job. IIL be damned. He did the same to his previous employer before joining IIL. Has a pattern of pursuing self interest under the guise of striking deals. Owner of Bharat Serum better beware!!?
Ex-Merind Staff, February 2017
I had been reading the comments to this column with great interest. I worked in a company called Merind where KV Balasubramaniam also worked. Merind gave him a great responsibility of starting a joint venture with Indian immunologicals and sent him as chief executive of the joint venture. However, when the owners of Merind decided to sack him, he took an age old practice perfected by medical representatives– he went on sick leave. He sold the idea of starting a human vaccines plant to Chairman of NDDB. He also hatched a plot to bring over all marketing staff of Merind animal health to IIL. This somehow did not quite materialize except a few naive persons who believed in KVB. Kvb then joined on the payroll of Indian immunologicals, and embarked upon the most disastrous strategy ever taken. He started a human vaccines venture, got the plant inaugurated by the President of India, and dragged the company into unprecedented losses for more than a decade. All this only to justify his existence. He brought out grandiose business plans, that were also quickly buried. He pompously declared that his plants would export vaccines to WHO. 15 years later, even the first plant is nowhere close to WHO Prequalification. The losses kept mounting though. In any private company he would have lost his job long back. Many subordinates lost their careers in his tughlaqian expedition though.
Indian Immunologicals Limited, Hyderabad 